Atlas Trials

Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

Clinical trial NCT00309309 · COMPLETED

Trial details

NCT number
NCT00309309
Sponsor
Mario Negri Institute for Pharmacological Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Transplant
Start date
2005-04-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.